08 November, 2025
The rise of biologics and biosimilars has transformed drug development, bringing forward new therapies like monoclonal antibodies (mAbs) and insulins. Yet, ensuring their quality and regulatory approval hinges on a key component: cell-based functional assays (CBFAs). In this blog, we highlight insights from Venture Center’s session on how CBFAs function as critical quality attributes (CQAs) in biologics development and biosimilar approval.
Read more
08 November, 2025
Targeted mass spectrometry (MS) has become a central technique in translational biology, bridging fundamental discovery work and real-world clinical validation. By allowing precise quantification of specific proteins, peptides, and metabolites, targeted MS helps answer critical biological questions, especially in metabolic and lifestyle diseases like diabetes.
Read more
29 August, 2025
Explore biophysical characterization tools for monoclonal antibodies, biosimilars, and complex biologics. Learn how CBA in India supports structural analysis, aggregation, glycan profiling, and mass spectrometry.
Read more
10 June, 2025
Antibody-based immunotherapies have transformed treatment for cancer, autoimmune diseases, and infections. Key to their action are Antibody-Dependent Cellular Cytotoxicity (ADCC) and Complement-Dependent Cytotoxicity (CDC). This blog explores the science behind these mechanisms and how CBA supports their testing and validation in India.
Read more
09 May, 2025
Elemental analysis is a foundational technique used across disciplines—from food safety to environmental monitoring and materials science. This session, part of Venture Center’s "Only One Analytical Technique" talk series, delved deep into this powerful analytical method, exploring its significance, techniques, and real-world applications.
Read more